Danielle Potter

696 total citations
23 papers, 393 citations indexed

About

Danielle Potter is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Economics and Econometrics. According to data from OpenAlex, Danielle Potter has authored 23 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 4 papers in Economics and Econometrics. Recurrent topics in Danielle Potter's work include Lung Cancer Treatments and Mutations (9 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Danielle Potter is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Danielle Potter collaborates with scholars based in United States, United Kingdom and Spain. Danielle Potter's co-authors include Peter P. Tóth, Eileen E. Ming, Jesús Rodríguez‐Baño, Kellie Ryan, Sònia Rojas‐Farreras, Sudeep Karve, Robert S. Miller, George A. Komatsoulis, Aliki Taylor and Jerzy E. Tyczynski and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Critical Care.

In The Last Decade

Danielle Potter

21 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danielle Potter United States	9	103	78	69	56	56	23	393
Bibek Poudel Nepal	13	56 0.5×	81 1.0×	71 1.0×	49 0.9×	41 0.7×	44	455
David J. Rosenberg United States	13	92 0.9×	36 0.5×	51 0.7×	95 1.7×	63 1.1×	16	507
Hsin‐Yin Hsu Taiwan	12	69 0.7×	59 0.8×	63 0.9×	48 0.9×	31 0.6×	33	324
Kate E. Shipman United Kingdom	11	123 1.2×	111 1.4×	48 0.7×	60 1.1×	18 0.3×	46	382
Tianyang Hu China	12	102 1.0×	99 1.3×	139 2.0×	83 1.5×	40 0.7×	42	465
Ladan Goshayeshi Iran	14	97 0.9×	59 0.8×	197 2.9×	34 0.6×	95 1.7×	56	568
Carmen Díaz‐Corte Spain	17	159 1.5×	44 0.6×	57 0.8×	36 0.6×	70 1.3×	42	776
Brian Radbill United States	10	81 0.8×	52 0.7×	98 1.4×	21 0.4×	30 0.5×	12	426
Jiaolong Ma China	12	55 0.5×	121 1.6×	83 1.2×	88 1.6×	29 0.5×	32	382

Countries citing papers authored by Danielle Potter

Since Specialization

Citations

This map shows the geographic impact of Danielle Potter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Potter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Potter more than expected).

Fields of papers citing papers by Danielle Potter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Potter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Potter. The network helps show where Danielle Potter may publish in the future.

Co-authorship network of co-authors of Danielle Potter

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Potter. A scholar is included among the top collaborators of Danielle Potter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Potter. Danielle Potter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nieva, Jorge J., Karen L. Reckamp, Danielle Potter, Aliki Taylor, & Ping Sun. (2022). Retrospective Analysis of Real-World Management of EGFR-Mutated Advanced NSCLC, After First-Line EGFR-TKI Treatment: US Treatment Patterns, Attrition, and Survival Data. Drugs - Real World Outcomes. 9(3). 333–345. 15 indexed citations

Alpert, Ash B., George A. Komatsoulis, Stephen C. Meersman, et al.. (2021). Identification of Transgender People With Cancer in Electronic Health Records: Recommendations Based on CancerLinQ Observations. JCO Oncology Practice. 17(3). e336–e342. 10 indexed citations

Jazieh, Abdul Rahman, et al.. (2021). Disruptions to U.S. medical oncology care during the COVID-19 Pandemic: CancerLinQ Discovery (CLQD) analysis.. Journal of Clinical Oncology. 39(15_suppl). 6547–6547.

Potter, Danielle, Aliki Taylor, Cathy Emmas, et al.. (2021). Summary of the 12 Most Common Cancers in the CancerLinQ Discovery (CLQD) Database. JCO Clinical Cancer Informatics. 5(5). 658–667. 9 indexed citations

Dewdney, Summer, Danielle Potter, Joy Larsen Haidle, et al.. (2020). Low rates of BRCA1 and BRCA2 testing for patients with ovarian cancer in ASCO's CancerLinQ, a real-world database.. Journal of Clinical Oncology. 38(15_suppl). 6041–6041. 4 indexed citations

Potter, Danielle, et al.. (2020). Disproportionate impact of COVID-19 disease among racial and ethnic minorities in the U.S. cancer population as seen in CancerLinQ Discovery data.. Journal of Clinical Oncology. 38(29_suppl). 84–84. 4 indexed citations

Potter, Danielle, Jacob E. Koskimaki, Robert S. Miller, et al.. (2020). Development of CancerLinQ, a Health Information Learning Platform From Multiple Electronic Health Record Systems to Support Improved Quality of Care. JCO Clinical Cancer Informatics. 929–937. 34 indexed citations

Schabath, Matthew B., Tapashi Dalvi, Hongyue Dai, et al.. (2019). <p>A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer</p>. Cancer Management and Research. Volume 11. 9469–9481. 1 indexed citations

Reckamp, Karen L., Jorge J. Nieva, Aliki Taylor, et al.. (2019). P1.01-105 US Real-World Management of EGFR-Mutated Advanced NSCLC: Prescribing and Attrition Data from First-To-Second-Line Treatment. Journal of Thoracic Oncology. 14(10). S402–S402. 4 indexed citations

10.

Ryan, Kellie, et al.. (2019). <p>The impact of initial antibiotic treatment failure: real-world insights in patients with complicated, health care-associated intra-abdominal infection</p>. Infection and Drug Resistance. Volume 12. 329–343. 21 indexed citations

11.

Nieva, Jorge J., Karen L. Reckamp, Aliki Taylor, et al.. (2019). P1.01-96 US Real-World Management of EGFR-Mutated Advanced NSCLC: Survival After First-Line EGFR-Tyrosine Kinase Inhibitor Treatment. Journal of Thoracic Oncology. 14(10). S398–S399.

12.

Ryan, Kellie, et al.. (2018). The impact of initial antibiotic treatment failure: Real-world insights in healthcare-associated or nosocomial pneumonia. Journal of Infection. 77(1). 9–17. 17 indexed citations

13.

Gray, Jhanelle E., Bharat Thakrar, Ping‐Hui Sun, et al.. (2018). Treatment (tx) patterns in patients (pts) with lung cancer starting 1st or 2nd generation (1G/2G) EGFR-TKI: A US insurance claims database analysis. Annals of Oncology. 29. ix156–ix157. 6 indexed citations

14.

Schabath, Matthew B., Tapashi Dalvi, Hongyue Dai, et al.. (2017). P1.01-042 Molecular Epidemiology of Programmed Cell Death 1-Ligand 1 (PD-L1) Protein Expression in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(1). S475–S476. 1 indexed citations

15.

Karve, Sudeep, et al.. (2017). The impact of initial antibiotic treatment failure: Real-world insights in patients with complicated urinary tract infection. Journal of Infection. 76(2). 121–131. 20 indexed citations

16.

Cronin‐Fenton, Deirdre, Tapashi Dalvi, Elizabeth Hedgeman, et al.. (2017). P2.01-043 PD-L1 Expression, EGFR and KRAS Mutations in First-Line Therapy (1L) for Non-Small Cell Lung Cancer (NSCLC) Patients. Journal of Thoracic Oncology. 12(11). S2085–S2086. 1 indexed citations

17.

Eccles, Diana, Judith Balmañà, B. Ehlken, et al.. (2016). Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review. Advances in Therapy. 33(2). 129–150. 33 indexed citations

18.

Potter, Danielle, Thomas G. Martin, Donald P. Dione, et al.. (2014). Sidestep and crossover lower limb kinematics during a prolonged sport-like agility test.. PubMed. 9(5). 617–27. 8 indexed citations

19.

Tóth, Peter P., Danielle Potter, & Eileen E. Ming. (2012). Prevalence of lipid abnormalities in the United States: The National Health and Nutrition Examination Survey 2003–2006. Journal of clinical lipidology. 6(4). 325–330. 198 indexed citations

20.

Hess, Gregory P., et al.. (2011). PCV64 ADHERENCE TO MEDICATIONS WITH ONCE-A-DAY (QD) AND TWICE-A-DAY (BID) DOSING FORMULATIONS IN ACUTE CORONARY SYNDROME (ACS) PATIENTS. Value in Health. 14(3). A44–A44. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact